The aim of this study was to evaluate reliability and psychiatric clinical value of quantum resonance spectrometer (QRS) in detection of affective disorders. We studied 1014 patients with schizophrenia and 248 patients with mood disorders (including 93 patients with major depression). Affective disorder symptoms of the same subjects obtained from the QRS test and psychiatrists' diagnoses were compared. In addition, three affective disorder symptoms of renumbered 93 patients with major depression were discriminated using QRS. Kappa values of affective disorder detection and diagnosis were more than 0.69 in all three symptoms of schizophrenia and more than 0.65 in six of seven symptoms of mood disorder. The same consistency could also be seen in receiver operating characteristic curve area under the curve. In the discriminated analysis, sensitivity, specificity, positive predictive value, and negative predictive value of hypothymia, anxiety, and irritability detected using QRS are more than 0.66 compared with psychiatrists' diagnoses. QRS could be an objective identification and diagnosis instrument and might promote psychiatric clinical diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/NMD.0000000000000120 | DOI Listing |
Psychiatr Pol
October 2024
Uniwersytet Medyczny w Poznaniu.
In 2024, we observe the fortieth anniversary of the publication, where, for the first time, the term of Seasonal Affective Disorder (SAD) was used. Presently, SAD is regarded as a special category of mood disorder. In the American Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V), the seasonality makes a specifier, "with seasonal pattern", both for recurrent depression or Major Depressive Disorder (MDD), and for Bipolar Disorder (BD).
View Article and Find Full Text PDFBrain Behav Immun
January 2025
Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, Australia; Department of Psychiatry, University of Melbourne, Melbourne, Australia. Electronic address:
Actas Dermosifiliogr
January 2025
Department of Dermatology, Hospital Universitario Miguel Servet IIS Aragón, Zaragoza, Spain.
Background: Psoriasis is a chronic disease with a prevalence of 3% in the general population. The high prevalence of psoriasis has prompted the study of its comorbidities in recent decades. However, no studies have ever analyzed comorbidity patterns including all chronic diseases in psoriatic patients.
View Article and Find Full Text PDFJ Affect Disord
January 2025
Department of Medicine and Surgery, Kore University of Enna, Italy; Oasi Research Institute-IRCCS, Troina, Italy. Electronic address:
Background: Clinical predictors of treatment-resistant depression could improve treatment strategies. Depressive symptom profiles at baseline are potential outcome predictors, but little evidence is available, and sex-specific profiles have been scarcely investigated.
Methods: Baseline symptom scores of 1294 patients with major depressive disorder were assessed by the Montgomery-Åsberg depression rating scale (MADRS) as part of a multicenter study by the "Group for the Studies of Resistant Depression".
West Afr J Med
September 2024
Mental Health Unit, Federal Medical Centre, Jabi, Abuja.
Background: Depression and anxiety disorders frequently co-occur with Type 2 Diabetes Mellitus, leading to poor glycaemic control and quality of life through complex biopsychosocial mechanisms. A dual diagnosis of chronic medical and mental health conditions reduces the probability of early recognition and intervention for either. This study was aimed at assessing the prevalence and correlates of depression and anxiety disorders among persons with Type 2 Diabetes Mellitus in a tertiary hospital in North-West Nigeria.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!